GENETIC AND ENVIRONMENTAL ASPECTS OF THE ROLE OF NICOTINIC RECEPTORS IN NEURODEGENERATIVE DISORDERS - EMPHASIS ON ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE

被引:76
作者
JAMES, JR [1 ]
NORDBERG, A [1 ]
机构
[1] KAROLINSKA INST, HUDDINGE UNIV HOSP, DEPT CLIN NEUROSCI & FAMILY MED, DIV NICOTINE RES, S-14186 HUDDINGE, SWEDEN
关键词
NICOTINIC RECEPTORS; ALZHEIMERS DISEASE; PARKINSONS DISEASE; GENETICS; ENVIRONMENTAL; NEUROPROTECTIVE;
D O I
10.1007/BF02196924
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
As neurodegenerative disorders are better characterized, the importance of genetic and environmental interactions is becoming more evident. Among the neurodegenerative disorders, Alzheimer's disease and Parkinson's disease are both characterized by large losses of nicotinic binding sites in brain. In addition, losses in nicotinic receptors occur during normal aging. Chronic administration of nicotine in man or experimental animals increases the number of nicotinic receptors in brain. Nicotine has been shown to possess some neuroprotective properties for both cholinergic and dopaminergic neurons. These neuroprotective properties, when better understood, may provide important information on normal aging and neurodegenerative disorder related neuronal cell death. Understanding the functional aspects of neuronal nicotinic receptor subtypes may lead to successful therapeutic treatments or disease preventative strategies for neurodegenerative disorders.
引用
收藏
页码:149 / 159
页数:11
相关论文
共 131 条
[41]   EXCITATORY AMINO-ACIDS AND ALZHEIMERS-DISEASE [J].
GREENAMYRE, JT ;
YOUNG, AB .
NEUROBIOLOGY OF AGING, 1989, 10 (05) :593-602
[42]   CHRONIC CONTINUOUS NICOTINE TREATMENT CAUSES DECREASED BURST FIRING OF NIGRAL DOPAMINE NEURONS IN RATS PARTIALLY HEMITRANSECTED AT THE MESO-DIENCEPHALIC JUNCTION [J].
GRENHOFF, J ;
JANSON, AM ;
SVENSSON, TH ;
FUXE, K .
BRAIN RESEARCH, 1991, 562 (02) :347-351
[43]   GENDER DIFFERENCES IN TOBACCO USE [J].
GRUNBERG, NE ;
WINDERS, SE ;
WEWERS, ME .
HEALTH PSYCHOLOGY, 1991, 10 (02) :143-153
[44]   NICOTINE EXPOSURE AND PARKINSON DISEASE [J].
HAACK, DG ;
BAUMANN, RJ ;
MCKEAN, HE ;
JAMESON, HD ;
TURBEK, JA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 114 (02) :191-200
[45]   NICOTINE FOR COLITIS - THE SMOKE HAS NOT YET CLEARED [J].
HANAUER, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (12) :856-857
[46]   TRANSMITTER DEFICITS IN ALZHEIMERS-DISEASE [J].
HARDY, J ;
ADOLFSSON, R ;
ALAFUZOFF, I ;
BUCHT, G ;
MARCUSSON, J ;
NYBERG, P ;
PERDAHL, E ;
WESTER, P ;
WINBLAD, B .
NEUROCHEMISTRY INTERNATIONAL, 1985, 7 (04) :545-563
[47]   DISTRIBUTION OF NICOTINIC CHOLINERGIC RECEPTORS IN THE RAT TELENCEPHALON AND DIENCEPHALON - A QUANTITATIVE RECEPTOR AUTORADIOGRAPHICAL STUDY USING [H-3] ACETYLCHOLINE, [ALPHA-I-125] BUNGAROTOXIN AND [H-3] NICOTINE [J].
HARFSTRAND, A ;
ADEM, A ;
FUXE, K ;
AGNATI, L ;
ANDERSSON, K ;
NORDBERG, A .
ACTA PHYSIOLOGICA SCANDINAVICA, 1988, 132 (01) :1-14
[48]   COMPLETE AND SELECTIVE CHOLINERGIC DENERVATION OF RAT NEOCORTEX AND HIPPOCAMPUS BUT NOT AMYGDALA BY AN IMMUNOTOXIN AGAINST THE P75 NGF RECEPTOR [J].
HECKERS, S ;
OHTAKE, T ;
WILEY, RG ;
LAPPI, DA ;
GEULA, C ;
MESULAM, MM .
JOURNAL OF NEUROSCIENCE, 1994, 14 (03) :1271-1289
[49]   PERFORMANCE, SUBJECTIVE, AND PHYSIOLOGICAL-EFFECTS OF NICOTINE IN NONSMOKERS [J].
HEISHMAN, SJ ;
SNYDER, FR ;
HENNINGFIELD, JE .
DRUG AND ALCOHOL DEPENDENCE, 1993, 34 (01) :11-18
[50]   EFFECTS OF NICOTINE GUM ON PSYCHOMOTOR PERFORMANCE IN SMOKERS AND NONSMOKERS [J].
HINDMARCH, I ;
KERR, JS ;
SHERWOOD, N .
PSYCHOPHARMACOLOGY, 1990, 100 (04) :535-541